FRAXA Announces 2012 Fragile X Research Awards

$1.13 million in FRAXA funding in 2012 supported new Fragile X research projects and renewals, advancing work toward better treatments.

Read More »

Fragile X Research Grants and Fellowships Funded 2011

Over $1 million in FRAXA funding in 2011 supported leading Fragile X research projects focused on developing effective treatments and future cures.

Read More »

FRAXA 2010 Research Awards Funded

Over $1.5 million in FRAXA funding supported Fragile X research and fellowships in 2010, empowering scientists to pursue breakthrough treatments.

Read More »

Results of First Fenobam Trial in Adults with Fragile X Published

Fenobam showed positive results in a Phase IIa Fragile X trial. FRAXA supplied data that helped the drug earn Orphan status and move into clinical testing.

Read More »

3 Researchers Honored at FRAXA Investigators Meeting

FRAXA’s 2008 Investigators Meeting brought together 150+ researchers from around the world to collaborate and speed new Fragile X therapies.

Read More »
Iryna Ethell, PhD, at University of California

Researchers Propose Minocycline to Treat Fragile X

Researchers found that minocycline, an available drug that blocks MMP-9, may improve Fragile X symptoms. This discovery inspired clinical trials.

Read More »

Categories

FRAXA Funded Research

Current Research Grants (42)